We appreciate the comments (1-5) on our research on the prevalence of plagiarism in residency application essays and the accompanying editorial by Papadakis and Wofsy (6). We agree with Dr. Siddique and colleagues (1) that an applicant's national origin should not excuse plagiarism, and we did not mean to imply otherwise. However, we caution that there is evidence of varying mores regarding copying of previously authored material in some cultures and that any response to our findings should be sensitive to such diversity (7).
Does the Relationship Between Hemoglobin A 1c and Mean Glucose Levels Differ by Race?
TO THE EDITOR: The glycated hemoglobin (HbA 1c ) assay has been widely accepted as an objective index of chronic glycemia, is universally used for diabetes management (1) , and has now been recommended for diagnosis (2) . The mathematical relationship between HbA 1c and mean glucose levels was established in the 1980s by small studies that compared self-monitored glucose levels over 5 to 8 weeks and HbA 1c level measured at the end of that period (1) . Recent studies have used more comprehensive measures, such as continuous glucose monitoring, to determine the relationship (3, 4) . These studies have demonstrated relatively higher correlation coefficients (R Ͼ 0.9) than those in previous studies with less frequent monitoring, emphasizing the need for comprehensive measures of glucose to capture true mean glycemia and accurately determine the relationship between mean glucose levels and HbA 1c . The largest such study was the ADAG (A1c-Derived Average Glucose) Study (4) . Unfortunately, only 8% of the ADAG population was African or African American, and power was limited to appreciate whether the relationship between mean glucose and HbA 1c differed among races. The difference in regression lines of mean glucose on HbA 1c between the non-Hispanic white and African American cohorts had a P value of 0.07. At the low (diagnostic) end of the glycemic spectrum, HbA 1c level for a similar mean glucose level was minimally higher (Ͻ0.13%) for African American persons than for non-Hispanic white persons. This borderline significant difference between races in the relationship between mean glucose and HbA 1c has been used to support the notion that HbA 1c levels differ for similar levels of mean glycemia in different races (5) . Several cross-sectional studies, including the recent study by Ziemer and colleagues (6), have been published supporting this conclusion; however, they have relied on very limited glucose measurements, ranging from a single timed glucose level to a single glucose tolerance test, to measure "mean glucose." These studies ignore the well-recognized variability in intrapatient, interday glucose values and the possibility that sampling error might explain their findings. Specifically, none of the investigators has considered that everyday glucose levels might differ between different racial groups, independent of the limited glucose levels on the day of testing. Whether the relationship between mean glucose levels and HbA 1c differs by race clearly needs to be determined and, if true, the magnitude of the difference and its clinical relevance should be determined. A study measuring glucose levels frequently enough to capture mean glucose levels with confidence, such as the ADAG Study, but including a large population from different races is necessary to address this issue satisfactorily. Until then, the current studies are neither scientifically valid nor compelling.
OBSERVATIONS

A Brugada-Pattern Electrocardiogram and Thyrotoxic Periodic Paralysis
Background: The Brugada syndrome is an inherited arrhythmogenic disease characterized by distinct coved-type ST-segment elevation in the right precordial leads with susceptibility to lifethreatening ventricular arrhythmias. Several medications and disease states may induce a Brugada-pattern electrocardiogram (ECG) in some patients, but whether these patients are at risk for ventricular arrhythmias is uncertain (1) .
Objective: To describe a patient with thyrotoxic periodic paralysis who had a Brugada-pattern ECG without evidence of genetically determined Brugada syndrome.
Case Report: An otherwise healthy 51-year-old man presented to our emergency department in January 2005 with sudden onset of bilateral leg weakness hours after having a large meal with liquor. On physical examination, we found marked reduction in proximal muscle strength and decreased deep tendon reflexes. Laboratory tests showed a low potassium level of 1.9 mmol/L, a glucose level of 7.9 mmol/L (144 mg/dL), a low thyroid-stimulating hormone level less than 0.004 mIU/L (normal range, 0.35 to 4.94 mIU/L), and an elevated free thyroxine level of 28.4 pmol/L (2.21 ng/dL) (normal range, 19.5 to 23.2 pmol/L [0.7 to 1.8 ng/dL]). The ECG showed J-point and ST-segment elevation of 1 mm in V 1 to V 2 ( Figure, top) . The patient's muscle weakness recovered shortly after intravenous administration of 40 mEq of potassium chloride. We prescribed oral methimazole and propranolol to control his hyperthyroidism. In October 2008, he had a recurrent episode of flaccid paralysis after a heavy, late-night meal. Laboratory tests showed a low potassium level of 2.3 mmol/L, an elevated glucose level of 13.7 mmol/L (248 mg/ dL), a low thyroid-stimulating hormone level of 0.1944 mIU/L, and a normal free thyroxine level of 16.9 pmol/L (1.31 ng/dL). He was afebrile. His ECG showed a PR interval of 240 ms; QRS width of 120 ms; and high-takeoff, coved ST-segment elevation greater than 2 mm followed by a negative T wave in V 1 to V 2 ( Figure, middle) . The ECG pattern normalized on resolution of hypokalemia and hyperglycemia (Figure, bottom) . Echocardiography was unremarkable. He had no family or personal history of syncope or aborted sudden death. A subsequent propafenone challenge test with ECG recording at upper intercostal spaces did not elicit a Brugada-pattern ECG. The patient declined genetic analysis for mutations implicated in the Brugada syndrome. He was managed conservatively and was doing well at 6-year follow-up.
Discussion: Hypokalemic periodic paralysis is a frequent complication of thyrotoxicosis in Asian men and is increasingly seen in Western countries. Observers postulate that increased sodium-potassium adenosine triphosphatase pump activity and enhanced insulin response cause a sudden intracellular shift of potassium that leads to hypokalemia (2, 3) . Others have reported that elevated insulin levels after meals unmask the Brugada syndrome mainly by activating the sodium-potassium adenosine triphosphatase pump, which increases the outward current (4), a mechanism that may explain the patient's Brugada-pattern ECG during his second paralytic episode when he had hyperglycemia.
We believe that an exaggerated insulin response to carbohydrate overindulgence could cause an imbalance of inward and outward currents in the right ventricular outflow tract sufficient to induce a Brugada-pattern ECG in patients with thyrotoxic periodic paralysis. Our patient had a Brugada-pattern ECG at a relatively normal free thyroxine level during his second paralytic episode, suggesting that a direct effect of thyroxine on myocardial ion channels does not explain the ECG findings. Others have reported that hypokalemia precipitates a Brugada-pattern ECG (1) and that a potassium channelopathy (mutated KCNE3 gene) is implicated in the pathogenesis of familial hypokalemic periodic paralysis and type 6 Brugada syndrome, but these findings were not associated with thyrotoxic periodic paralysis in a large Chinese cohort (5, 6). Our patient's prolonged PR interval and QRS complex suggest depolarization abnormalities, but we do not know whether these findings are related to genetic abnormalities, and we know that the Brugada-pattern ECG can be a transient phenomenon in people who do not have the genetically determined disease (7) . In addition, our patient's negative propafenone test result favors an acquired rather than a genetic explanation for his Brugada-pattern ECG.
Conclusion: To our knowledge, this is the first report of an acquired Brugada-pattern ECG in a thyrotoxic patient, and we postulate that the Brugada-pattern ECG and hypokalemic periodic paralysis might have a common underlying mechanism.
Objective: To describe a patient with adrenal insufficiency who had a Brugada-pattern ECG.
Case Report: A 47-year-old man with a history of hypothyroidism and no coronary artery disease presented to our hospital with progressive weakness, dizziness, and weight loss of 4 weeks' duration. He was unable to stand because of dizziness and an impending sense of collapse. He had no family history of syncope or sudden cardiac death. He was hypotensive (blood pressure, 70/30 mm Hg) with a pulse of 85 beats/min, and physical examination was otherwise unremarkable. Laboratory data showed a sodium level of 124 mmol/L, potassium level of 6.7 mmol/L, chloride level of 95 mmol/L, and bicarbonate level of 18 mmol/L. His cardiac enzyme levels were within normal limits, and he had normal thyroid function test results.
On his initial ECG, we noted RBBB with coved Brugada-type ST-T wave changes in V 1 and V 2 , along with borderline first-degree atrioventricular block (Figure 1, top) . After 2 hours of rehydration and electrolyte repletion, a repeated ECG showed incomplete RBBB with saddleback-type 1-mm ST-segment elevation in V 1 and V 2 (Figure 1, middle) . Twenty-four hours later, the Brugada pattern resolved, with persistence of first-degree atrioventricular block and an incomplete RBBB (Figure 1, bottom) .
Echocardiography yielded normal results. Further investigation revealed a low serum cortisol level (Ͻ5.52 nmol/L), high adrenocorticotropic hormone level (15 pmol/L), and positive antiadrenal antibody indicating primary adrenal insufficiency. Steroid supplementation was initiated. Follow-up ECGs showed resolution of the Brugada-pattern changes.
Discussion: In 1992, the Brugada brothers reported a distinct subgroup of patients with episodes of "idiopathic" polymorphic ventricular tachycardia or ventricular fibrillation characterized by a unique ECG pattern, which consisted of RBBB and ST-segment elevation from V 1 to V 2 and V 3 . Observers have described 3 different patterns of ST-segment elevation (1) . The classic Brugada type 1 ECG has an elevated ST segment (Ն2 mm) descending with an upward convexity to an inverted T wave, whereas the type 2 and type 3 patterns have a saddleback ST-T wave configuration, in which the elevated ST segment descends toward the baseline, then rises again to an upright or a biphasic T wave. The ST segment is elevated by 1 mm or more in type 2 and by less than 1 mm in type 3. Observers have reported the ECG patterns of the Brugada syndrome with fever, hyperkalemia, hypercalcemia, and exposure to certain medications (1) (2) (3) (4) .
Hyperkalemia, a common electrolyte disturbance in adrenal insufficiency, produces the Brugada pattern by decreasing the resting membrane potential, which inactivates the cardiac sodium channels. The decrease in the inward sodium current results in the domination of the outward potassium current. The outward potassium current is more active in the epicardial cells than in the endocardium and the M cells, and this activity is most pronounced in the right ventricle. The ECG changes are the result of a transient, outward, currentmediated notch in the action potential and subsequent loss of the action potential dome in the epicardium of the right ventricular outflow tract, giving rise to a transmural voltage gradient (Figure 2 ) (4) . Conditions that amplify this outward current (in this case, hyperkalemia) precipitate the Brugada pattern.
This patient's history of hypothyroidism and the new diagnosis of primary adrenal insufficiency are consistent with the Schmidt syndrome (polyglandular autoimmune syndrome type 2). Other investigators have found abnormalities of ion channel function in some patients with the Schmidt syndrome and some with the Brugada syndrome. For example, some patients with the Schmidt syndrome also have myasthenia gravis, an autoimmune channelopathy (5). In addition, the SCN5A mutation that encodes the ␣ subunit of the cardiac sodium channel gene is a common cause of the Brugada syndrome (1) .
Conclusion: Adrenal insufficiency is a rare cause of a Brugadapattern ECG and should be considered a differential diagnosis in patients with these ECG findings and negative cardiac enzyme findings. 
